ARGIPAC

Serial Number 75807484
606

Registration Progress

Application Filed
Sep 24, 1999
Under Examination
Aug 14, 2001
Approved for Publication
May 9, 2001
Published for Opposition
May 22, 2001
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: ARGIPAC
Previous Owner: eNOS Pharmaceuticals, Inc.
Classes: 005

Trademark Image

ARGIPAC

Basic Information

Serial Number
75807484
Filing Date
September 24, 1999
Published for Opposition
May 22, 2001
Abandonment Date
February 15, 2002
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 15, 2002
Classes
005

Rights Holder

eNOS Pharmaceuticals, Inc.

03
Address
58 Charles Street
Cambridge, MA 02141

Ownership History

eNOS Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

eNOS Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Legal Representation

Attorney
Rodger L. Tate

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Aug 20, 2002 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 14, 2001 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 22, 2001 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 9, 2001 NPUB O NOTICE OF PUBLICATION Loading...
Jan 4, 2001 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 28, 2000 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 28, 2000 CNRT F NON-FINAL ACTION MAILED Loading...
Jan 20, 2000 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR INTRAVENOUS ADMINISTRATION FOR THE TREATMENT OF STROKES; PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR TREATMENT OF STROKES; PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR TREATMENT OF PATIENTS WHO HAVE OR ARE AT HIGH RISK FOR HAVING ATHEROSCLEROSIS, HIGH CHOLESTEROL, HYPER-LIPIDEMIA, PULMONARY EDEMA, NEUROLOGICAL DISORDERS, CARDIO-VASCULAR DISEASE, CEREBRAL VASCULAR ACCIDENTS, OR APOPLEXY; AND MEDICATIONS FOR THE TREATMENT OF STOKES; PHARMACEUTICAL PREPARATIONS, NAMELY, L-ARGININE PREPARATIONS FOR INTRAVENOUS ADMINISTRATION FOR THE TREATMENT OF STROKES
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
ARGI PAC; ARGI PACK

Classification

International Classes
005